The context of prostate cancer genomics in personalized medicine

Oncology Letters
Yanling Liu

Abstract

Prostate cancer is one of the most common types of cancer in males. Heterogeneous genomic aberrations may lead to prostate cancer onset, progression and metastasis. This heterogeneity also contributes to the variety in cancer risk and outcomes, different drug responses and progression, observed between individual patients. Classical prognostic factors, including prostate-specific antigen, Gleason Score and clinical tumor staging, are not sufficient to portray the complexity of a clinically relevant cancer diagnosis, risk prognosis, treatment choice and therapy monitoring. There is a requirement for novel genetic biomarkers in order to understand the oncogenic heterogeneity in a patient-personalized clinical setting and to improve the efficacy of risk prognosis and treatment choice. A number of biomarkers and gene panels have been established from patient sample cohort studies. These previous studies have provided distinct information to the investigation of heterogeneous malignancy in prostate cancer, which aids in clinical decision-making. Biomarker-guided therapies may facilitate the effective selection of drugs during early treatment; therefore, are beneficial to the individual patient. A non-invasive approach allows for con...Continue Reading

References

Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yan Ping YuJian-Hua Luo
Nov 19, 2004·European Urology·Patrick J BastianWilliam G Nelson
Jun 9, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mark A RubinJan-Erik Johansson
Jul 31, 2007·Molecular Medicine·Victor TrevinoHugo A Barrera-Saldaña
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karsten GravdalLars A Akslen
Sep 17, 2009·JAMA : the Journal of the American Medical Association·Grace L Lu-YaoSiu-Long Yao
Jan 28, 2010·British Journal of Cancer·A H M ReidUNKNOWN Transatlantic Prostate Group
Mar 4, 2010·Current Molecular Medicine·N Shivapurkar, A F Gazdar
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·Samuel Myllykangas, Hanlee P Ji
Mar 26, 2011·Pharmacological Reviews·Qiang Ma, Anthony Y H Lu
May 18, 2011·Prostate Cancer and Prostatic Diseases·E S Antonarakis, A J Armstrong
May 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Isaac KindeBert Vogelstein
Jun 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel C DanilaHoward I Scher
Nov 15, 2011·Nature Biotechnology·Tim R MercerJohn L Rinn
Mar 31, 2012·Science Translational Medicine·John R PrensnerArul M Chinnaiyan
Apr 19, 2012·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·George RodriguesUNKNOWN Genitourinary Radiation Oncologists of Canada
May 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Saswati MahapatraKrishna Vanaja Donkena
Jun 23, 2012·Nature·Catherine S GrassoScott A Tomlins
May 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jamie R SchoenbornMin Fang
Jun 29, 2013·Seminars in Oncology·Randy Schrecengost, Karen E Knudsen
Jan 8, 2014·Prostate Cancer and Prostatic Diseases·Z PengC Li
Jan 21, 2014·European Urology·Stacy LoebRuth Etzioni
Jun 7, 2014·Frontiers in Oncology·Dana Olsen, Jan Trøst Jørgensen
Jun 21, 2014·International Journal of Biological Sciences·Barbara KahnNatasha Kyprianou
Jun 25, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Felix Y FengArul M Chinnaiyan
Jul 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Haley HieronymusCharles L Sawyers
Jul 23, 2014·Medical Oncology·Amrallah A Mohammed
Sep 10, 2014·Cancers·Genevieve HousmanSibaji Sarkar
Sep 23, 2014·BioMed Research International·C G H RönnauJ A Schalken
Oct 4, 2014·Journal of Hematology & Oncology·Alan D SmithTimothy A Yap
Oct 30, 2014·Journal of Molecular Endocrinology·Ye ZhouJeremy O Jones
Nov 27, 2014·Neoplasia : an International Journal for Oncology Research·John R PrensnerFelix Y Feng
Dec 17, 2014·Current Pharmaceutical Design·Mohammad Imran KhanHasan Mukhtar

❮ Previous
Next ❯

Citations

Mar 1, 2018·Convergent Science Physical Oncology·Paymaneh D MalihiPeter Kuhn
Mar 7, 2021·Cancers·Amaal Ali, George Kulik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.